KaleidoMyco
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
KaleidoMyco - overview
Location
-, -, US
Primary Industry
Consumer Products
About
Based in the US, KaleidoMyco operates as a manufacturer and seller of various kinds of myco-dosing products to treat skin fungal infections such as pressed pills, effervescent, muscle creams, anti-aging moisturizers, etc. In February 2021, Global Wellness Strategies bid acquired KaleidoMyco. The firm offers supplement products that help in fungal treatment. It uses myco and hemp extracts along with adaptogens.
It offers functional fizz and One shot. The functional fizz offered by the firm is in the form of a drink and is a mixture of functional mushrooms and hemp extract. The one-shot offered by the company is a one-shot blend of functional mushrooms and hemp extract.
Primary Industry
Consumer Products
Sub Industries
Beauty & Hygiene, Biopharmaceuticals
Website
https://kaleidomyco.com/
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.